Impact of neoadjuvant chemotherapy on the efficacy of sugammadex for neuromuscular block reversal in ovarian cancer patients: A prospective cohort study

The study indicated that in patients who underwent NAC, the time from sugammadex administration to TOFr ≥0.9, the recovery index, and the extubation time were prolonged. Additionally, these patients experienced an textended onset time, a shortened clinical duration, and an increased average dosage of rocuronium.